ATE537453T1 - Selektion intrazellulärer immunglobuline - Google Patents

Selektion intrazellulärer immunglobuline

Info

Publication number
ATE537453T1
ATE537453T1 AT00909465T AT00909465T ATE537453T1 AT E537453 T1 ATE537453 T1 AT E537453T1 AT 00909465 T AT00909465 T AT 00909465T AT 00909465 T AT00909465 T AT 00909465T AT E537453 T1 ATE537453 T1 AT E537453T1
Authority
AT
Austria
Prior art keywords
selection
immunoglobulins
intracellular
immunoglobulin
target
Prior art date
Application number
AT00909465T
Other languages
English (en)
Inventor
Eric Tse
Terence Rabbits
Antonio Cattaneo
Michela Visintin
Original Assignee
Medical Res Council
Scuola Internaz Superiore Di Studi Avanzati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council, Scuola Internaz Superiore Di Studi Avanzati filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE537453T1 publication Critical patent/ATE537453T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
AT00909465T 1999-03-10 2000-03-10 Selektion intrazellulärer immunglobuline ATE537453T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9905510A GB2344886B (en) 1999-03-10 1999-03-10 Selection of intracellular immunoglobulins
PCT/GB2000/000876 WO2000054057A1 (en) 1999-03-10 2000-03-10 Selection of intracellular immunoglobulins

Publications (1)

Publication Number Publication Date
ATE537453T1 true ATE537453T1 (de) 2011-12-15

Family

ID=10849353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00909465T ATE537453T1 (de) 1999-03-10 2000-03-10 Selektion intrazellulärer immunglobuline

Country Status (10)

Country Link
US (2) US7569390B1 (de)
EP (1) EP1166121B1 (de)
AT (1) ATE537453T1 (de)
AU (2) AU777038B2 (de)
CA (1) CA2277561C (de)
DK (1) DK1166121T3 (de)
ES (1) ES2379154T3 (de)
GB (1) GB2344886B (de)
PT (1) PT1166121E (de)
WO (1) WO2000054057A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028502A1 (en) * 1997-11-28 1999-06-10 Invitrogen Corporation Single chain monoclonal antibody fusion reagents that regulate transcription in vivo
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
EP1242457B1 (de) * 1999-12-28 2004-08-11 Esbatech AG Intrakörper mit definierter struktur ("framework"), die in einer reduzierenden umgebung stabil ist, und ihre verwendungen
IT1317922B1 (it) * 2000-10-24 2003-07-15 S I S S A Scuola Internaz Supe Metodo per identificare in vivo epitopi intracellulari.
US6610472B1 (en) * 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
AU2002355477B2 (en) 2001-08-03 2008-09-25 Medical Research Council Method of identifying a consensus sequence for intracellular antibodies
AU2003219277A1 (en) * 2002-03-14 2003-09-29 Medical Research Council Intracellular antibodies
GB0226727D0 (en) * 2002-11-15 2002-12-24 Medical Res Council Intrabodies
GB0226723D0 (en) * 2002-11-15 2002-12-24 Medical Res Council Antibodies for in vitro use
ATE428778T1 (de) * 2002-04-26 2009-05-15 Chugai Pharmaceutical Co Ltd Verfahren zum screening auf agonistische antikörper
EP2332989B1 (de) 2002-05-22 2015-04-01 ESBATech, an Alcon Biomedical Research Unit LLC Immunoglobulinrahmen mit verbesserter Stabilität im intrazellulären Raum und Verfahren zu deren Identifizierung
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
GB0226729D0 (en) * 2002-11-15 2002-12-24 Medical Res Council Intracellular antibodies
GB0226731D0 (en) * 2002-11-15 2002-12-24 Medical Res Council Method for generating immunoglobulin genes
ITRM20020588A1 (it) * 2002-11-21 2004-05-22 Lay Line Genomics Spa Metodo per isolare anticorpi intracellulari neutralizzanti di interazioni proteiche.
FR2869416B1 (fr) * 2004-04-27 2007-01-12 Centre Nat Rech Scient Cnrse Procede d'identification d'un ligand capable de moduler selectivement une cascade fonctionnelle impliquant une cible et ses applications pour le criblage a haut-debit de molecules d'interet.
US8841238B2 (en) 2007-03-15 2014-09-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for producing active scFv antibodies and libraries therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
JP5933894B2 (ja) 2007-09-14 2016-06-15 アディマブ， エルエルシー 合理的に設計された、合成抗体ライブラリおよびその使用
US12529164B2 (en) 2007-09-14 2026-01-20 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP2188372A4 (de) * 2007-09-17 2011-03-02 Affomix Corp Erhöhung der spezifizität in einem scfv-sieb mithilfe von dual-bait-reportern
GB0911215D0 (en) 2009-06-29 2009-08-12 Univ Erasmus Medical Ct Gamma globin therapy
KR102810907B1 (ko) 2010-07-16 2025-05-21 아디맵 엘엘씨 항체 라이브러리
US12024568B2 (en) 2012-09-13 2024-07-02 Cornell University Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
SMT202100008T1 (it) 2013-05-06 2021-03-15 Scholar Rock Inc Composizioni e metodi per la modulazione di fattore di crescita
US20160355573A1 (en) * 2013-09-05 2016-12-08 Cornell University Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
EP4183806A3 (de) 2014-11-12 2023-08-02 Seagen Inc. Glycaninteragierende verbindungen und verfahren zur verwendung
ITUB20155272A1 (it) 2015-11-02 2017-05-02 Scuola Normale Superiore Intracellular antibody
CN108463248B (zh) 2015-11-12 2022-10-21 西雅图基因公司 聚糖相互作用化合物及使用方法
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
WO2018160909A1 (en) 2017-03-03 2018-09-07 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US20190175506A1 (en) 2017-11-17 2019-06-13 Codiak Biosciences, Inc. Loading of Extracellular Vesicles through Imparting of Mechanical Shear

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499183A (en) * 1982-12-21 1985-02-12 Ortho Diagnostic Systems Inc. Detecting intracellular antigens in swelled and fixed cells with labeled antibody
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
CA2068190C (en) * 1991-05-15 1996-12-17 Microgenics Corporation Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
AU6266896A (en) * 1995-06-07 1996-12-30 Eukarion, Inc. Transvacular and intracellular delivery of lipidized protein s
US6083693A (en) * 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins

Also Published As

Publication number Publication date
GB9905510D0 (en) 1999-05-05
AU777038B2 (en) 2004-09-30
AU4237099A (en) 2000-09-14
EP1166121B1 (de) 2011-12-14
CA2277561C (en) 2011-08-30
WO2000054057A1 (en) 2000-09-14
EP1166121A1 (de) 2002-01-02
DK1166121T3 (da) 2012-03-26
CA2277561A1 (en) 2000-09-10
AU3174700A (en) 2000-09-28
US7569390B1 (en) 2009-08-04
GB2344886B (en) 2000-11-01
PT1166121E (pt) 2012-03-21
ES2379154T3 (es) 2012-04-23
US20090317822A1 (en) 2009-12-24
US7897347B2 (en) 2011-03-01
GB2344886A (en) 2000-06-21
ES2379154T9 (es) 2012-06-25

Similar Documents

Publication Publication Date Title
ATE537453T1 (de) Selektion intrazellulärer immunglobuline
DK1151300T3 (da) Assay til påvisning af en bindingspartner
ATE315228T1 (de) Immunoassay zum bestimmen von bnp
ES2180538T3 (es) Suministro dirigido de vector virico a celulas de mamiferos.
WO2002043477A1 (fr) Methode d'obtention d'une souris adaptee a la prise, a la differenciation et a la proliferation de cellules heterogenes, souris obtenue selon cette methode et son utilisation
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
ATE491239T1 (de) Integriertes modul für festoxid- brennstoffzellensystem
TR200101484T2 (tr) Alzheimer hastalığı sekretazı
DK0749325T3 (da) Bispecifikke molekyler med klinisk anvendelse
WO1997029183A3 (en) Methods and compositions for transforming dendritic cells and activating t cells
BR0313145A (pt) Sistema de célula eletroquìmica, célula metal-ar e método de operar um sistema de célula eletroquìmica
DK1348124T3 (da) Identifikation af individuelle celler under kinetiske assays
ATE170092T1 (de) Künstliche rezeptoren, antikörper und enzyme
EP1042500A4 (de) Verwendung einer festphase für einen enzymassay
CA2071173A1 (en) B12 enzyme immunoassay and sample pretreatment
DK0837699T3 (da) Immunovektor, som kan anvendes til intracellulær- og intranekleær transport
FR2709202B1 (fr) Installation de chargement d'assemblages combustibles.
WO2002051988A3 (en) Thymic epithelial progenitor cells and uses thereof
AU2909100A (en) Routing
EP1021728B8 (de) Versuchsanordnungen, antikörper und standards für den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
EP1452595A4 (de) Es-zellen mit verstärktem rnai-effekt
AU2813200A (en) Assay for measuring different enzyme activities simultaneously
WO2000077241A3 (en) Heparanase assay
NO20015494L (no) Fremgangsmåte for dyrking av celler
ATE18805T1 (de) Untersuchung mit zyto-rezeptoren.